DNA DIAGNOSTIC - LeanGene Partnership

21 Apr 2021

DNA DIAGNOSTIC & LeanGene sign a partnership agreement to bring HemaVision® line of chromosomal translocation associated with leukemia to LGn's regional market.

LeanGene (LGn) is pleased to announce its partnership agreement with DNA DIAGNOSTIC, one of the leaders in developing PCR assays used for the screening of translocations associated with the development of leukemia.

This line will add greatly to our molecular diagnostics portfolio and will give more strength to our oncology solutions.

We are very pleased about this collaboration that will fulfill our market's need.

DNA Diagnostic A/S is a privately owned Danish biotech company founded in 1992, specialized in the development of PCR (Polymerase Chain Reaction) and qPCR (Quantitative Polymerase Chain Reaction), test kits for food safety, animal and human health care.

DNA Diagnostic's vision is to improve global food safety and diagnostics for leukemia patients by developing and producing fast and easy qPCR kits. They strive for the market leading position within fast and easy qPCR testing for food safety, veterinary and human health care diagnostics.

Learn more about DNA-DIAGNOSTIC